These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 3471179

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics of ciprofloxacin tablets in renal failure; influence of haemodialysis.
    Singlas E, Taburet AM, Landru I, Albin H, Ryckelinck JP.
    Eur J Clin Pharmacol; 1987; 31(5):589-93. PubMed ID: 3830244
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis.
    Francke EL, Appel GB, Neu HC.
    Antimicrob Agents Chemother; 1979 Dec; 16(6):788-91. PubMed ID: 533260
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of ofloxacin in healthy subjects and patients with impaired renal function.
    Höffler D, Koeppe P.
    Drugs; 1987 Dec; 34 Suppl 1():51-5. PubMed ID: 3125032
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO, Wåhlin-Boll E, Odar-Cederlöf I, Lindholm L, Melander A.
    Eur J Clin Pharmacol; 1989 Dec; 36(2):165-74. PubMed ID: 2721541
    [Abstract] [Full Text] [Related]

  • 31. Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis.
    Singlas E, Taburet AM, Borsa Lebas F, Parent de Curzon O, Sobel A, Chauveau P, Viron B, al Khayat R, Poignet JL, Mignon F.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1519-24. PubMed ID: 1510449
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.
    Blum RA, Kohli RK, Harrison NJ, Schentag JJ.
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1470-6. PubMed ID: 2817847
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Pharmacokinetics of habekacin in patients with chronic renal insufficiency].
    Fillastre JP, Leroy A, Humbert G, Moulin B, Bernadet P, Josse S.
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):739-41. PubMed ID: 3309806
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.
    Shyu WC, Pittman KA, Wilber RB, Matzke GR, Barbhaiya RH.
    J Clin Pharmacol; 1991 Apr; 31(4):362-71. PubMed ID: 2037710
    [Abstract] [Full Text] [Related]

  • 40. Multiple dose kinetics of ofloxacin and ofloxacin metabolites in haemodialysis patients.
    Kampf D, Borner K, Pustelnik A.
    Eur J Clin Pharmacol; 1992 Apr; 42(1):95-9. PubMed ID: 1541323
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.